Biogen Announces Two New Nominees for Election to Board of Directors
Nominees bring diverse business and public health experience key to Biogen’s mission to pioneer and lead in neuroscienceCompany thanks Director...
Month: April 2021
Genmab and Seagen Announce U.S. FDA Filing Acceptance for Priority Review of Tisotumab Vedotin Biologics License Application for Patients with Recurrent or Metastatic Cervical Cancer
Company Announcement FDA action date is Oct 10, 2021BLA submission supported by positive pivotal innovaTV 204 trial results presented at...
Scilex Holding, a Subsidiary of Sorrento, Has Received From FDA a sNDA Approval for ZTlido® Label Expansion
PALO ALTO, Calif., April 09, 2021 (GLOBE NEWSWIRE) -- Scilex Holding (“Scilex”), an over 99% owned subsidiary of Sorrento Therapeutics...
Convocation annual general meeting and extraordinary general shareholders meeting
Regulated informationNazareth (Belgium)/Rotterdam (Netherlands), 9 April 2021 Convocation annual general meeting and extraordinary general shareholders meeting The board of directors...
Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas
Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas PARIS AND...
Why COVID is just the tip of a terrifying, but potentially revolutionary, antibiotic resistant iceberg
LONDON, April 09, 2021 (GLOBE NEWSWIRE) -- Based in the UK, SpectrumX is currently raising capital to expand its testing...
Fulcrum Therapeutics Presents Published Structure of Investigational Small Molecule FTX-6058 at the American Chemical Society (ACS) Spring 2021 Virtual Conference
Company initiates dosing in Phase 1 healthy volunteer multiple ascending dose (MAD) cohortCAMBRIDGE, Mass., April 09, 2021 (GLOBE NEWSWIRE) -- Fulcrum...
Genetic Technologies Provides Update on COVID-19 Risk Test Launch
MELBOURNE, Australia, April 09, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics...
Axiom Presents “Unified Platforms: Key Modules and Data Considerations for Study Success” at Outsourcing in Clinical Trials Israel 2021
TEL AVIV, Israel, April 09, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions...
BioSig Invited to Join Alliance for Artificial Intelligence in Healthcare (AAIH)
Westport, CT, April 09, 2021 (GLOBE NEWSWIRE) -- Global leaders, including Amazon, Bayer, and GE Healthcare, joined the AAIH to...
Merit Medical Systems to Announce First Quarter Results on April 29, 2021
SOUTH JORDAN, Utah, April 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer...
Vericel to Present at the 20th Annual Needham Virtual Healthcare Conference on Thursday, April 15, 2021
CAMBRIDGE, Mass., April 09, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...
Sona Establishes an At-The-Market Common Share Offering
Halifax, Nova Scotia--(Newsfile Corp. - April 9, 2021) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona")...
Phyto Extractions(TM) (Adastra Labs) Launches New Shatter Product Line to Canadian Retail Market in Time for 420
LANGLEY, BC / Accesswire / April 9, 2021 / Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX)(Frankfurt:D2EP) ("Phyto Extractions™"...
TRxADE Group to Present at Planet MicroCap Showcase
CEO Suren Ajjarapu to Present Wednesday, April 21st, 2021 TAMPA, FL / ACCESSWIRE / April 9, 2021 / Trxade Group,...
Aptevo Therapeutics to Present at the American Association for Cancer Research Virtual Annual Meeting
SEATTLE, WA / ACCESSWIRE / April 9, 2021 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing...
Theralase Commences Collaborative Research with National Microbiology Laboratory for Development of Coronavirus Vaccine
TORONTO, ON / ACCESSWIRE / April 9, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
CureVac to Report Fourth Quarter and Full-Year 2020 Financial Results and Business Updates on April 15, 2021
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / April 9, 2021 / CureVac N.V. (Nasdaq:CVAC), a biopharmaceutical company developing a...
Syapse Showcases Real-World Mortality Data in American Society of Clinical Oncology’s JCO-CCI
Study validates Syapse’ Composite Mortality Score methodology and its ability to overcome disparities driven by social determinants of health in...
Sana Biotechnology Presents Preclinical Data at American Association for Cancer Research Annual Meeting 2021
– Targeted in vivo gene delivery of a CAR using a CD8-specific fusogenresults in tumor eradication –– Hypoimmune CAR T...